ArticleFrontiers in immunology2026
Improving screening for antibody deficiency using calculated globulin and serum protein electrophoresis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Antibody deficiencies, particularly Common Variable Immunodeficiency (CVID), represent a major health concern due to comorbidities linked to delayed diagnosis. Calculated globulin (CG) and the gammaglobulins derived from serum protein electrophoresis have been proposed as reliable indices for screening hypogammaglobulinemia. This study aimed to establish optimal cut-offs for CG and the gammaglobulins to identify patients with low IgG among hospitalized adolescents and adults from Algeria. Methods: Serum samples and clinical data were collected from hospitalized patients aged over 10 years. Total protein and albumin were determined by the biuret and bromocresol green methods, IgG was quantified by nephelometry, and gammaglobulins were determined by gel or capillary serum protein electrophoresis. In addition, a control group was included for cut-off verification. Results: A total of 980 patients were recruited, including 762 adults (≥ 18 years) and 218 adolescents (10-17 years), with a median age of 47 years. The control group comprised 20 patients with confirmed CVID. The most frequent clinical manifestations were autoimmune disorders (33%), inflammatory disorders (31%), and severe infections (24%). Hypogammaglobulinemia was identified in 94 patients, including 6 with primary causes. IgG levels correlated significantly with both CG and gammaglobulins. Linear regression analysis showed that IgG accounted for 49% of the variance in CG and 75% in the gammaglobulins. A CG cut-off value of 22 g/L yielded a sensitivity of 80% and a specificity of 87%, whereas a gammaglobulin cut-off of 8.9 g/L achieved a sensitivity of 96% and a specificity of 88%. Gammaglobulin cut-off values were consistent between adult and pediatric groups, while differences in CG cut-offs were observed (adult group: 22.25 g/L; pediatric group: 24.15 g/L). Thirteen of the 20 patients with CVID in the control group (65%) had a CG level below 22 g/L. Conclusion: CG and serum protein electrophoresis are reliable tools for screening hypogammaglobulinemia. Although both tests demonstrated satisfactory sensitivity and specificity, certain cases may be underestimated or overestimated. Therefore, thorough clinical evaluation and, whenever possible, direct immunoglobulin measurement remain essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.